+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032- Product Image
Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032- Product Image
Sale

Enzymes for ß-lactam Antibiotics Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126449
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enzymes for β-lactam Antibiotics Market is projected to reach USD 238.57 Million in 2026. It is expected to continue growing at a CAGR of 11.93%, reaching USD 467.82 Million by 2032.

Enzymes for β-Lactam Antibiotics: Executive Overview

Enzymes used in the manufacture, modification, protection, and quality control of β-lactam antibiotics support a technically demanding pharmaceutical value chain. Their relevance is shaped by the need for selective biocatalysis, reliable impurity control, regulatory compliance, and robust supply of critical medicines including penicillins, cephalosporins, carbapenems, and related compounds. The market is influenced by antimicrobial-resistance concerns, stricter environmental expectations, advances in fermentation, and continued demand for efficient antibiotic production.

Biocatalysis and Resilience Are Reshaping β-Lactam Production

The landscape is shifting from conventional chemical processing toward more selective enzymatic routes where they can reduce harsh reaction conditions, improve stereochemical control, and simplify downstream purification. Enzyme engineering, immobilization, continuous processing, and improved fermentation platforms are expanding the range of commercially practical applications. At the same time, manufacturers are placing greater emphasis on process resilience, qualified alternative suppliers, traceability of biological inputs, and compliance with evolving pharmaceutical and environmental requirements.

Artificial Intelligence Accelerates Enzyme Discovery and Process Optimization

Artificial intelligence is contributing to enzyme sequence screening, structure prediction, activity assessment, and the prioritization of candidates for laboratory testing. In manufacturing, data-driven tools can help optimize fermentation parameters, identify process deviations, improve batch consistency, and support predictive maintenance. These benefits remain dependent on high-quality experimental data, interpretable validation, biosafety controls, and integration with established quality systems. AI therefore complements rather than replaces biochemical experimentation, regulatory review, and process-development expertise.

Regional Dynamics Reflect Manufacturing Capacity and Regulatory Context

North America combines advanced biotechnology capabilities with stringent pharmaceutical-quality expectations and strong interest in resilient domestic supply chains. Europe emphasizes sustainable processing, environmental performance, and harmonized regulatory practice, while the European Union provides an important framework for cross-border pharmaceutical manufacturing. Asia-Pacific is central to large-scale pharmaceutical production and enzyme development, with China, India, Japan, South Korea, and Australia contributing distinct capabilities. Latin America is shaped by access to essential medicines, import dependencies, and opportunities for localized production. The Middle East is investing in healthcare and industrial diversification, while Africa’s priorities include reliable antibiotic access, technology transfer, and strengthening pharmaceutical manufacturing capacity.

Economic and Security Groupings Shape Collaboration and Supply Strategy

ASEAN economies provide a diverse manufacturing and distribution base, with opportunities for regional pharmaceutical integration and technology transfer. BRICS members span major pharmaceutical, chemical, and biotechnology capabilities, but differ substantially in regulatory systems and production infrastructure. The European Union supports coordinated standards and cross-border supply networks. G7 economies contribute advanced research, quality systems, and high-value manufacturing expertise. GCC countries are pursuing healthcare resilience and industrial diversification, while NATO members bring together substantial pharmaceutical demand, research capacity, and supply-chain security priorities. These groupings can facilitate collaboration, but regulatory alignment and access to qualified inputs remain essential.

Country-Level Capabilities Range from Discovery to Large-Scale Manufacturing

Australia contributes research capacity and advanced healthcare infrastructure; Brazil and Mexico are important Latin American pharmaceutical markets with opportunities to strengthen local production. Canada and the United States combine biotechnology research, sophisticated regulation, and established pharmaceutical capabilities. China and India are major manufacturing and active-pharmaceutical-ingredient hubs, with growing attention to process efficiency and supply resilience. France, Germany, Italy, Spain, and the United Kingdom contribute deep pharmaceutical, chemical, and life-science expertise within stringent regulatory environments. Japan and South Korea are recognized for advanced manufacturing, quality control, and biotechnology development. Russia retains pharmaceutical and chemical capabilities, while its operating environment is affected by trade, regulatory, and supply-chain constraints.

Prioritize Qualified Supply, Enzyme Innovation, and Compliance by Design

Industry leaders should qualify multiple sources for critical enzymes and biological inputs, establish clear specifications for activity and impurities, and use risk-based supplier oversight. Investment should focus on enzyme engineering, immobilization, fermentation control, and analytical methods that improve selectivity and reproducibility. Organizations should deploy AI first in well-governed applications such as candidate prioritization and process monitoring, with human review and documented validation. Regional manufacturing partnerships, technology-transfer programs, and contingency inventories can improve resilience. Sustainability goals should be linked to measurable reductions in solvent use, energy intensity, waste, and water consumption while maintaining pharmaceutical quality.

Methodology: Evidence-Based Review of Technology, Regulation, and Supply Chains

This executive summary uses a qualitative synthesis of established evidence categories relevant to enzymes for β-lactam antibiotics, including peer-reviewed biocatalysis and fermentation research, public pharmaceutical and antimicrobial-resistance guidance, regulatory frameworks, technical standards, and documented industry practices. Findings were organized across technological development, manufacturing processes, regional conditions, economic groupings, country capabilities, artificial-intelligence applications, and supply-chain resilience. Claims were limited to broadly supportable structural insights; no market estimates, market shares, forecasts, or company-specific assessments were used.

Selective Enzymatic Manufacturing Supports a More Resilient Antibiotic Value Chain

Enzymes for β-lactam antibiotics occupy an important position at the intersection of pharmaceutical manufacturing, biotechnology, sustainability, and medicine security. Progress will depend on combining reliable biological production with rigorous analytics, responsible AI adoption, diversified sourcing, and regulatory discipline. Leaders that connect enzyme innovation with operational resilience and measurable environmental performance will be better positioned to support consistent access to quality β-lactam antibiotics across diverse regions and healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Enzymes for ß-lactam Antibiotics Market, by Enzyme Type
7.1. Introduction
7.2. Penicillin Acylases
7.2.1. Penicillin G Acylase
7.2.2. Penicillin V Acylase
7.3. Cephalosporin Acylases
7.3.1. Cephalosporin C Acylase
7.3.2. 7-ACA Acylase
7.4. Aminopenicillin Acylases
7.4.1. Amoxicillin Acylase
7.4.2. Ampicillin Acylase
7.5. Carbapenem-related Enzymes
7.5.1. Imipenem Synthesis Enzymes
7.5.2. Meropenem Synthesis Enzymes
7.6. Auxiliary Enzymes
7.6.1. Esterases
7.6.2. Amidases
7.6.3. ß-lactamases
8. Enzymes for ß-lactam Antibiotics Market, by Product Form
8.1. Introduction
8.2. Free Enzyme
8.3. Immobilized Enzyme
8.3.1. Adsorption
8.3.2. Covalent Bonding
8.3.3. Encapsulation
8.3.4. Entrapment
9. Enzymes for ß-lactam Antibiotics Market, by Source Organism
9.1. Introduction
9.2. Microbial
9.2.1. Bacterial
9.2.1.1. Escherichia coli
9.2.1.2. Bacillus Species
9.2.1.3. Streptomyces Species
9.2.2. Fungal
9.2.2.1. Aspergillus Species
9.2.2.2. Penicillium Species
9.3. Animal
9.3.1. Porcine
9.3.2. Bovine
9.4. Plant
9.5. Recombinant / Engineered
9.5.1. Genetically Modified Bacterial Hosts
9.5.2. Yeast Hosts
9.5.3. Fungal Hosts
10. Enzymes for ß-lactam Antibiotics Market, by Application
10.1. Introduction
10.2. Cephalosporin Synthesis
10.2.1. Cefadroxil
10.2.2. Cephalexin
10.3. Penicillin Synthesis
10.3.1. Penicillin G
10.3.2. Penicillin V
11. Enzymes for ß-lactam Antibiotics Market, by End User
11.1. Introduction
11.2. Contract Manufacturing Organizations
11.3. Pharmaceutical Manufacturers
12. Enzymes for ß-lactam Antibiotics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Enzymes for ß-lactam Antibiotics Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Enzymes for ß-lactam Antibiotics Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Amicogen, Inc.
16.3. Aurobindo Pharma Limited
16.4. Biosynth AG
16.5. Centrient Pharmaceuticals Netherlands B.V.
16.6. Cipla Limited
16.7. Creative Enzymes, Inc.
16.8. Eucodis Bioscience GmbH
16.9. Fermenta Biotech Limited
16.10. GlaxoSmithKline plc
16.11. Hikma Pharmaceuticals PLC
16.12. Lupin Limited
16.13. Merck & Co., Inc.
16.14. Merck KGaA
16.15. Novartis AG
16.16. Pfizer Inc.
16.17. Sanofi
16.18. Sun Pharmaceutical Industries Limited
16.19. Teva Pharmaceutical Industries Ltd.
16.20. Wockhardt Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Enzymes for ß-lactam Antibiotics Market, Years Considered for the Study
FIGURE 2. Global Enzymes for ß-lactam Antibiotics Market, Research Design
FIGURE 3. Global Enzymes for ß-lactam Antibiotics Market, Research Framework
FIGURE 4. Global Enzymes for ß-lactam Antibiotics Market, Data Triangulation
FIGURE 5. Global Enzymes for ß-lactam Antibiotics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2025 vs 2032 (%)
FIGURE 7. Global Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 9. Global Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2025 vs 2032 (%)
FIGURE 11. Global Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Enzymes for ß-lactam Antibiotics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Enzymes for ß-lactam Antibiotics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Enzymes for ß-lactam Antibiotics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Enzymes for ß-lactam Antibiotics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Enzymes for ß-lactam Antibiotics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Enzymes for ß-lactam Antibiotics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Enzymes for ß-lactam Antibiotics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Enzymes for ß-lactam Antibiotics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Enzymes for ß-lactam Antibiotics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Enzymes for ß-lactam Antibiotics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Enzymes for ß-lactam Antibiotics Market Segmentation & Coverage
TABLE 2. Global Enzymes for ß-lactam Antibiotics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 4. Global Penicillin Acylases Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Penicillin Acylases Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Penicillin Acylases Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Penicillin G Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Penicillin G Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Penicillin G Acylase Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Penicillin V Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Penicillin V Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Penicillin V Acylase Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Cephalosporin Acylases Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Cephalosporin Acylases Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Cephalosporin Acylases Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cephalosporin C Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cephalosporin C Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cephalosporin C Acylase Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global 7-ACA Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global 7-ACA Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global 7-ACA Acylase Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Aminopenicillin Acylases Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Aminopenicillin Acylases Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Aminopenicillin Acylases Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Amoxicillin Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Amoxicillin Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Amoxicillin Acylase Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Ampicillin Acylase Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Ampicillin Acylase Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Ampicillin Acylase Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Carbapenem-related Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Carbapenem-related Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Carbapenem-related Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Imipenem Synthesis Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Imipenem Synthesis Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Imipenem Synthesis Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Meropenem Synthesis Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Meropenem Synthesis Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Meropenem Synthesis Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Auxiliary Enzymes Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Auxiliary Enzymes Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Auxiliary Enzymes Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Esterases Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Esterases Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Esterases Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Amidases Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Amidases Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Amidases Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global ß-lactamases Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global ß-lactamases Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global ß-lactamases Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 53. Global Free Enzyme Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Free Enzyme Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Free Enzyme Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Immobilized Enzyme Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Immobilized Enzyme Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Immobilized Enzyme Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Adsorption Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Adsorption Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Adsorption Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Covalent Bonding Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Covalent Bonding Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Covalent Bonding Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Encapsulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Encapsulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Encapsulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Entrapment Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Entrapment Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Entrapment Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 72. Global Microbial Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Microbial Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Microbial Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Escherichia coli Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Escherichia coli Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Escherichia coli Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Bacillus Species Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Bacillus Species Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Bacillus Species Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Streptomyces Species Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Streptomyces Species Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Streptomyces Species Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Aspergillus Species Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Aspergillus Species Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Aspergillus Species Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Penicillium Species Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Penicillium Species Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Penicillium Species Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Animal Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Animal Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Animal Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Plant Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Plant Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Plant Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Recombinant / Engineered Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Recombinant / Engineered Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Recombinant / Engineered Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Genetically Modified Bacterial Hosts Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Genetically Modified Bacterial Hosts Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Genetically Modified Bacterial Hosts Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Yeast Hosts Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Yeast Hosts Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Yeast Hosts Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Fungal Hosts Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Fungal Hosts Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Fungal Hosts Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Global Cephalosporin Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Cephalosporin Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Cephalosporin Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Cefadroxil Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Cefadroxil Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Cefadroxil Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Cephalexin Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Cephalexin Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Cephalexin Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Penicillin Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Penicillin Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Penicillin Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Penicillin G Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Penicillin G Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Penicillin G Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Penicillin V Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Penicillin V Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Penicillin V Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Pharmaceutical Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Pharmaceutical Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Pharmaceutical Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. North America Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. North America Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 168. North America Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 169. North America Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 170. North America Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 171. North America Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 172. North America Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 173. North America Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 174. North America Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 175. North America Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 176. North America Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 177. North America Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 178. North America Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 179. North America Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 180. North America Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 181. North America Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. North America Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 183. North America Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 184. North America Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 187. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 188. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 189. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 190. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 191. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 192. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 193. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 194. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 195. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 196. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 197. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 198. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 199. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 200. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 202. Latin America Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 203. Latin America Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Europe Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Europe Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 206. Europe Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 207. Europe Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 208. Europe Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 209. Europe Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 210. Europe Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 211. Europe Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 212. Europe Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 213. Europe Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 214. Europe Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 215. Europe Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 216. Europe Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 217. Europe Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 218. Europe Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 219. Europe Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Europe Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 221. Europe Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 222. Europe Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 224. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 225. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 226. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 227. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 228. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 229. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 230. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 231. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 232. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 233. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 234. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 235. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 236. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 237. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 238. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 240. Middle East Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 241. Middle East Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Africa Enzymes for ß-lactam Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Africa Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 244. Africa Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 245. Africa Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 246. Africa Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 247. Africa Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 248. Africa Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 249. Africa Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 250. Africa Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 251. Africa Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 252. Africa Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 253. Africa Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 254. Africa Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 255. Africa Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 256. Africa Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 257. Africa Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 258. Africa Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 259. Africa Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 260. Africa Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Global Enzymes for ß-lactam Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 262. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 264. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 265. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 266. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 267. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 268. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 269. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 270. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 271. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 272. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 273. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 274. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 275. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 276. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 277. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 279. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 280. ASEAN Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. GCC Enzymes for ß-lactam Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 282. GCC Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 283. GCC Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 284. GCC Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 285. GCC Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 286. GCC Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 287. GCC Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 288. GCC Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 289. GCC Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 290. GCC Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 291. GCC Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 292. GCC Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 293. GCC Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 294. GCC Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 295. GCC Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 296. GCC Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. GCC Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 298. GCC Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 299. GCC Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. European Union Enzymes for ß-lactam Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 301. European Union Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 302. European Union Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 303. European Union Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 304. European Union Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 305. European Union Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 306. European Union Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 307. European Union Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 308. European Union Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 309. European Union Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 310. European Union Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 311. European Union Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 312. European Union Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 313. European Union Enzymes for ß-lactam Antibiotics Market Size, by Animal, 2017-2032 (USD Million)
TABLE 314. European Union Enzymes for ß-lactam Antibiotics Market Size, by Recombinant / Engineered, 2017-2032 (USD Million)
TABLE 315. European Union Enzymes for ß-lactam Antibiotics Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. European Union Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Synthesis, 2017-2032 (USD Million)
TABLE 317. European Union Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Synthesis, 2017-2032 (USD Million)
TABLE 318. European Union Enzymes for ß-lactam Antibiotics Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 320. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Enzyme Type, 2017-2032 (USD Million)
TABLE 321. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Penicillin Acylases, 2017-2032 (USD Million)
TABLE 322. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Cephalosporin Acylases, 2017-2032 (USD Million)
TABLE 323. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Aminopenicillin Acylases, 2017-2032 (USD Million)
TABLE 324. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Carbapenem-related Enzymes, 2017-2032 (USD Million)
TABLE 325. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Auxiliary Enzymes, 2017-2032 (USD Million)
TABLE 326. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 327. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Immobilized Enzyme, 2017-2032 (USD Million)
TABLE 328. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Source Organism, 2017-2032 (USD Million)
TABLE 329. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Microbial, 2017-2032 (USD Million)
TABLE 330. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Bacterial, 2017-2032 (USD Million)
TABLE 331. BRICS Enzymes for ß-lactam Antibiotics Market Size, by Fungal, 2017-2032 (USD Million)
TABLE 332. BRICS Enzymes for ß-lactam Antibiotics Market Size, by

Companies Mentioned

  • AbbVie Inc.
  • Amicogen, Inc.
  • Aurobindo Pharma Limited
  • Biosynth AG
  • Centrient Pharmaceuticals Netherlands B.V.
  • Cipla Limited
  • Creative Enzymes, Inc.
  • Eucodis Bioscience GmbH
  • Fermenta Biotech Limited
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Merck & Co., Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Limited

Related Topics

Related Reports

Enzymes Market 2024-2028 - Product Image

Enzymes Market 2024-2028

  • Report
  • 149 Pages
  • Global
From
Enzymes - Global Strategic Business Report - Product Image

Enzymes - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Immobilized Penicillin G Acylase Market - Global Forecast 2026-2032 - Product Image

Immobilized Penicillin G Acylase Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Penicillin G Acylase Market - Global Strategic Business Report - Product Image

Penicillin G Acylase Market - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Semi-synthetic ß-lactam Antibiotics Market - Global Forecast 2026-2032 - Product Image

Semi-synthetic ß-lactam Antibiotics Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.